Walker on Progress

A look at the WindRunner, the world's largest aircraft by volume, and how its ability to move massive rockets intact could rewrite the rules of space.

Bracco Imaging enters the cell therapy toolkit market with BubbleGen, a microbubble tech aiming to replace magnetic beads for T-cell isolation. Can it solve CAR-T's biggest bottlenecks?

Alterome Therapeutics brings on a heavy-hitting CFO in Johanna Mylet, who guided Poseida to an IPO and Roche acquisition. What does this signal for its future?

With its new IRIS series, JMGO isn't just launching a projector. It's firing a warning shot with aggressive pricing and technology that challenges the market's old guard.

A second sell-out seems imminent as On and FP Movement fuse tech and style. We dissect the strategy, from scarcity marketing to a multi-channel retail play.

Inovalon's ScriptMed now electronically transfers specialty scripts, ending the fax-and-call era to speed up patient care and slash pharmacy workloads.

GitLab posts strong 21% revenue growth, leveraging its financial momentum to double down on AI and flexible enterprise models, navigating a complex market.

Adicet Bio nears a pivotal data readout for its lupus CAR-T, now viable for outpatient use, while launching a novel solid tumor attack in prostate cancer.

A new partnership between Ripple and SettleMint aims to solve digital asset fragmentation for banks, offering a unified platform for the booming APAC market.

As the AI cyber arms race heats up, UST hosts GenCyS 2026 to foster secure innovation, develop new talent, and spotlight India's rising tech scene.

A new poll shows Americans have faith in election mechanics but worry legal battles could invalidate their votes, putting immense pressure on local officials.

Inconsistent data and legacy systems create a silent crisis, eroding profits and client trust. A new focus on data architecture offers a path forward.

A new AI chatbot, "Ask Coach John," is turning the youth sports tech model on its head by delivering curated expert advice directly to anxious parents.

Crescendo's new all-in-one platform isn't just adding AI; it's rebuilding the CX stack from scratch. Can this AI-native model truly end the silo era?

The iconic Commodore brand is back in publishing, betting on a beloved Amiga IP. We dissect the strategy, tech, and market forces behind this nostalgic play.

A quiet revolution is reshaping private capital as family offices eclipse traditional funds. We dissect how Privea Partners is building the bridge to this new wealth.

Indian manufacturer Zeon Lifesciences has secured key U.S. regulatory approvals, offering American brands a new, quality-vetted partner in a shifting market.

A massive equipment auction offers a lifeline to contractors, but it's also the final act in a coal company's collapse, revealing deep market shifts.

The sickle cell drugmaker engineered a stunning Q2 profit, but a deep dive reveals a radical strategic bet on outsourcing its commercial backbone.

A new coaster and resort are just the start. We dissect how a $150M investment in Ozarks heritage aims to transform a theme park into a national destination.